|1||NCT03345095||Not yet recruiting||A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma||
||Other / Industry||
||750||All||18 Years and older (Adult, Senior)||NCT03345095||EORTC-BTG-1709||June 2018||June 2022||June 2023||November 17, 2017||April 6, 2018||
|2||NCT02903069||Recruiting||Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer||
||Industry / Other||
||72||All||18 Years and older (Adult, Senior)||NCT02903069||MRZ-112||April 15, 2016||June 18, 2019||May 31, 2020||September 16, 2016||April 11, 2018||
† Study has passed its completion date and status has not been verified in more than two years.